Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 01:24PM ET
0.1541
Dollar change
+0.0006
Percentage change
0.39
%
Index- P/E- EPS (ttm)-1.90 Insider Own29.69% Shs Outstand54.39M Perf Week-35.93%
Market Cap8.38M Forward P/E- EPS next Y- Insider Trans6.13% Shs Float38.25M Perf Month-41.98%
Income-69.68M PEG- EPS next Q- Inst Own14.87% Short Float7.33% Perf Quarter12.07%
Sales0.00M P/S- EPS this Y- Inst Trans-0.61% Short Ratio1.37 Perf Half Y-13.52%
Book/sh-2.36 P/B- EPS next Y- ROA-157.49% Short Interest2.80M Perf Year-94.10%
Cash/sh0.52 P/C0.30 EPS next 5Y34.40% ROE- 52W Range0.09 - 3.59 Perf YTD5.98%
Dividend Est.- P/FCF- EPS past 5Y-15.44% ROI-279.34% 52W High-95.71% Beta2.18
Dividend TTM- Quick Ratio2.47 Sales past 5Y0.00% Gross Margin- 52W Low80.66% ATR (14)0.03
Dividend Ex-Date- Current Ratio2.47 EPS Y/Y TTM19.41% Oper. Margin0.00% RSI (14)32.10 Volatility16.02% 12.67%
Employees31 Debt/Eq- Sales Y/Y TTM- Profit Margin- Recom3.00 Target Price0.25
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q44.55% Payout- Rel Volume1.47 Prev Close0.15
Sales Surprise- EPS Surprise- Sales Q/Q- EarningsMar 28 BMO Avg Volume2.05M Price0.15
SMA20-31.44% SMA50-23.47% SMA200-78.32% Trades Volume1,869,299 Change0.39%
Date Action Analyst Rating Change Price Target Change
Aug-10-23Downgrade Piper Sandler Overweight → Neutral $6 → $0.50
Oct-19-21Downgrade BTIG Research Buy → Neutral
Oct-19-21Downgrade BofA Securities Buy → Underperform $17 → $2
Apr-26-21Resumed Credit Suisse Outperform $15
Dec-16-20Upgrade Credit Suisse Neutral → Outperform $9 → $15
Dec-07-20Initiated H.C. Wainwright Buy $15
Dec-02-19Initiated Credit Suisse Neutral
Dec-02-19Initiated Citigroup Buy
Dec-02-19Initiated BTIG Research Buy
Dec-02-19Initiated BofA/Merrill Buy
Today 11:53AM
07:00AM
Nov-14-23 07:00AM
Oct-31-23 07:00AM
Sep-18-23 07:00AM
07:00AM Loading…
Sep-05-23 07:00AM
Aug-18-23 12:00PM
Aug-16-23 10:00AM
Aug-14-23 07:00AM
Aug-11-23 10:34AM
Aug-10-23 10:12AM
Aug-09-23 06:30PM
04:31PM
Jun-28-23 08:11AM
Jun-05-23 02:15PM
08:45AM Loading…
May-18-23 08:45AM
08:00AM
May-11-23 07:00AM
May-04-23 04:01PM
May-01-23 07:00AM
Apr-26-23 10:00AM
Mar-10-23 07:00AM
Mar-08-23 09:53AM
07:00AM
Feb-15-23 12:43PM
08:45AM
08:00AM
Feb-05-23 07:35AM
Dec-12-22 11:37AM
07:00AM
07:00AM Loading…
Nov-22-22 07:00AM
Nov-09-22 07:00AM
Nov-07-22 10:08AM
Oct-26-22 03:16PM
01:40PM
Sep-26-22 07:00AM
Sep-06-22 07:00AM
Sep-01-22 07:00AM
Aug-29-22 06:47AM
Aug-09-22 07:00AM
Jun-29-22 12:05PM
07:30AM
Jun-02-22 07:00AM
May-30-22 11:11AM
May-26-22 05:00PM
May-16-22 02:25PM
07:30AM
07:00AM
May-02-22 07:00AM
Apr-27-22 10:00AM
Mar-21-22 06:34PM
Mar-10-22 07:00AM
Jan-06-22 07:00AM
Dec-15-21 08:30AM
Dec-14-21 01:06PM
11:31AM
10:51AM
07:00AM
05:22AM
Nov-16-21 09:08AM
Nov-15-21 07:00AM
Nov-10-21 07:00AM
Nov-02-21 09:04AM
Oct-28-21 07:23AM
Oct-25-21 02:39PM
Oct-21-21 12:00PM
Oct-20-21 10:16AM
Oct-19-21 12:11PM
07:00AM
Oct-15-21 08:23AM
Oct-12-21 07:00AM
Oct-05-21 02:52PM
Sep-14-21 07:00AM
Sep-08-21 07:00AM
Sep-07-21 07:00AM
Aug-16-21 08:01AM
Aug-10-21 07:00AM
Jun-28-21 07:00AM
Jun-03-21 04:00AM
May-26-21 07:00AM
May-17-21 07:00AM
May-12-21 04:01PM
May-11-21 07:00AM
May-05-21 07:00AM
Apr-29-21 06:28AM
Apr-28-21 04:01PM
Mar-11-21 07:00AM
Mar-10-21 08:00AM
Feb-19-21 02:39AM
Dec-07-20 04:26PM
Nov-20-20 08:00AM
Nov-10-20 07:00AM
Nov-03-20 08:00AM
Oct-27-20 03:00PM
Oct-23-20 05:00PM
Oct-22-20 08:00AM
Oct-20-20 10:02AM
Sep-22-20 08:00AM
Sep-16-20 08:00AM
Sep-14-20 08:00AM
Galera Therapeutics, Inc. is a clinical stage biotechnology company, which engages in developing and commercializing a pipeline of novel, proprietary therapeutics for cancer. It is also involved in the prevention of radiation-induced toxicity, including mucositis and the treatment of fibrosis, and cancer. The company was founded by Robert A. Beardsley, Randy W. Weiss, and Dennis P. Riley in 2009 and is headquartered in Malvern, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Schneid Yair10% OwnerFeb 08 '24Buy0.17150,00025,6508,043,203Feb 26 04:06 PM
Schneid Yair10% OwnerFeb 07 '24Buy0.17175,00030,1857,893,203Feb 26 04:06 PM
Schneid Yair10% OwnerFeb 06 '24Buy0.2025,0005,0257,718,203Feb 26 04:06 PM
Schneid Yair10% OwnerFeb 05 '24Buy0.1897,40217,9227,693,203Feb 26 04:06 PM
Schneid Yair10% OwnerJan 30 '24Buy0.18335,00060,6357,595,801Feb 26 04:06 PM
Schneid Yair10% OwnerJan 29 '24Buy0.18150,00027,0007,260,801Feb 26 04:06 PM